None listed
Conditions
Brief summary
This study looks at the impact of physical activity on fatigue and quality of life in people with thoracic lung cancer. Who is it for? You may be eligible to join this study if you have invasive thoracic cancer which is not suitable for surgical removal. Trial details: Participants will be divided into two groups. One group (the control group) will receive standard care for 6 months. The other group will take part in a physical activity program, with behavioural support for 8 weeks in addition to standard care. Study aims: To compare self-reported fatigue levels and quality of life in the two groups to determine the effects of exercise.
Interventions
Participants randomised to the intervention group will take part in an 8-week personalised physical activity program. The type (e.g. aerobic, resistance or flexibility), and intensity of the sessions will be tailored to the fitness level and preferences of the individual participant.
The physical activity sessions are for 1 hour / week for 8 weeks and also include a behavioural support session.
The behavioural support sessions include topics such as goal setting, plainng, motivation and time man
Participants randomised to the intervention group will take part in an 8-week personalised physical activity program. The type (e.g. aerobic, resistance or flexibility), and intensity of the sessions will be tailored to the fitness level and preferences of the individual participant. The physical activity sessions are for 1 hour / week for 8 weeks and also include a behavioural support session. The behavioural support sessions include topics such as goal setting, plainng, motivation and time management. The physical activity sessions are conducted face-to-face with an exercise physiologist or physiotherapist. They can be one-on-one or in a small group, depending on the preference of the participant. The behavioural sessions can be either face-to-face or over the phone with a member of the research team.
Sponsors
Janette Vardy
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Diagnosis of non-resectable invasive lung cancer, eg non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC). 2. Completion of treatment at least 4 weeks prior to study involvement for patients with Stage III NSCLC or Limited SCLC. 3. Age of a least 18 years. 4. Medically fit to participate on a physical activity programme. 5. Ability to complete study questionnaires in English. 6. Give written informed consent. 7. Completion of screening questionnaires within 14 days of registration.
Exclusion criteria
1. Eastern Cooperative Oncology Group (ECOG) Performance Status of 3 or more. 2. Pre-existing significant comorbidities that preclude participation in a physical activity programme. 3. Life expectancy of less than 6 months. 4. Insufficient English fluency to complete questionnaires. 5. Inability to complete baseline exercise test done prior to randomisation
Outcome results
None listed